Phenobarbital Pharmacokinetics and Optimal Dosing of Phenobarbital
Researchers from the Baylor College of Medicine in Houston, TX, USA, conducted a retrospective population pharmacokinetic analysis of 355 patients ages less than 19 years of age in the inpatient setting who were initiated on intravenous or oral phenobarbital therapy and had one or more serum phenoba...
Saved in:
Main Authors: | Safiullah Shareef (Author), Murtaza Nasir Ali (Author) |
---|---|
Format: | Book |
Published: |
Pediatric Neurology Briefs Publishers,
2018-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High-Dose Phenobarbital for Ohtahara Syndrome
by: J Gordon Millichap
Published: (2002) -
Physiologically based pharmacokinetic modeling for dose optimization of quinine-phenobarbital coadministration in patients with cerebral malaria
by: Teerachat Sae‐heng, et al.
Published: (2022) -
What Is the Best Predictor of Phenobarbital Pharmacokinetics to Use for Initial Dosing in Neonates?
by: Martin Šíma, et al.
Published: (2021) -
Phenobarbital: missing in action
by: Neshan B Ilangaratne, et al.
Published: (2012) -
Phenobarbital-Induced Depression
by: J Gordon Millichap
Published: (1990)